This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n9http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q92828496
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xunu de 2019 im Juni 2019 veröffentlichter wissenschaftlicher Artikel scientific article published on 17 June 2019 наукова стаття, опублікована 17 червня 2019 wetenschappelijk artikel
p:P577
wds:Q92828496-239DA503-DD6E-4A31-8166-AC701FE192C4
wdt:P577
2019-06-17T00:00:00Z
p:P2093
wds:Q92828496-C15F226F-23E7-4325-B681-B0151E4B6B7E wds:Q92828496-AB833BA5-7E5B-46D5-9A70-41A713A278AA wds:Q92828496-BE2FF4D8-A753-4773-843C-447FB15642E6 wds:Q92828496-F2D127C9-2F00-4748-904D-59C324E8B251 wds:Q92828496-DA5181EA-25EF-46BB-BEE5-E314A987FD75 wds:Q92828496-4CFF5B52-A4CD-4974-9934-E9A4A9BD96FC wds:Q92828496-489FA138-5C75-4097-8BFC-ED8E6AA30CBB wds:Q92828496-891A4E32-F3CD-43D0-88DE-F74983F5293C wds:Q92828496-9CC88691-5336-4C58-9C9D-E784A90EF641 wds:Q92828496-0DB8D270-7C2E-47E0-AC6B-7364AD22087B wds:Q92828496-2BEF65BD-6F2D-479A-A9D2-C4520FF3776D wds:Q92828496-2789E512-1E04-427F-A115-6E7B9DACBAB1
wdt:P2093
Yoshihiro Nishida Akihito Nagano Hirohisa Katagiri Akihiro Sudo Yoji Shido Kenji Yamada Kunihiro Ikuta Katsuhisa Kawanami Satoshi Yamada Daisuke Ishimura Eiji Kozawa Kunihiro Asanuma
rdfs:label
The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study
skos:prefLabel
The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study
schema:name
The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study
p:P50
wds:Q92828496-495E22F5-986C-43EE-80FA-DC43C65DEACF wds:Q92828496-84307038-3FD1-4355-96DA-569306198DEE
wdt:P50
wd:Q88434887 wd:Q79698604
p:P1476
wds:Q92828496-DE54D9B9-E991-43F2-9569-30A4C53ABED5
wdt:P1476
The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study
p:P304
wds:Q92828496-0D8FA9A4-D755-4835-9599-B015F0F9ACE9
wdt:P304
343-350
p:P31
wds:Q92828496-FE73E323-1CA0-4A33-91C0-E202B8FDB703
wdt:P31
wd:Q13442814
p:P698
wds:Q92828496-54B695B2-3E52-4241-A80B-A5AC5D4B2E70
wdtn:P698
n12:31209624
wdt:P698
31209624
p:P1433
wds:Q92828496-35A9A7B5-3BBD-46B4-8930-A97F534B1C56
wdt:P1433
wd:Q13470030
p:P433
wds:Q92828496-CE78FB90-D2EB-4317-B0F6-FED356FF7AE5
p:P478
wds:Q92828496-73C9E847-A6A4-41E7-87BB-303CC72E0373
wdt:P433
4
wdt:P478
36
p:P356
wds:Q92828496-DFD26616-68E5-470B-B6E9-67A88E53353D
wdtn:P356
n9:S10585-019-09980-3
wdt:P356
10.1007/S10585-019-09980-3